The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 2 |Faculty of Medicine Universitas Airlangga
2025
Indonesian Society of Respirology Position Paper on Lung Cancer Control in Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 2 |Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)
2024
Hubungan Karakteristik dengan Klasifikasi Kejadian Ikutan pasca Imunisasi COVID-19 pada Tenaga Kesehatan di Kota Padang
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 4 |Syntax Corporation
2024
LENT Score as a Prognosis Factor for Overall Survival and Progression-Free Survival in Malignant Pleural Effusion Patients at Tertiary Hospitals in West Sumatera, Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |HM Publisher
2023
LENT Score as a Prognosis Factor for Overall Survival and Progression-Free Survival in Malignant Pleural Effusion Patients at Tertiary Hospitals in West Sumatera, Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |HM Publisher
2023
Indonesian Society of Respirology (ISR) Consensus Statement on Lung Cancer Screening and Early Detection in Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 2 |Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)
2023
Profil Pasien COVID-19 dengan Komorbid yang Dirawat di RSUP Dr. M. Djamil Padang
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 4 |Fakultas Kedokteran, Universitas Andalas
2023
Management of Resistance to Targeted Therapy in EGFR Mutational Lung Adenocarcinoma: A Case Report
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |HM Publisher
2023
Management of Resistance to Targeted Therapy in EGFR Mutational Lung Adenocarcinoma: A Case Report
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |HM Publisher
2023
Immunotherapy in Lung Cancer: A Narrative Literature Review
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |HM Publisher
2023
Immunotherapy in Lung Cancer: A Narrative Literature Review
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |HM Publisher
2023
High Levels of Leucocyte and Thrombocyte Increasing COVID-19 Mortality Rate in RSUP Dr. M. Djamil Padang
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 2 |Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)
2023
Effect of Radon and Lung Cancer Risk: A Narrative Literature Review
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |HM Publisher
2022
Profile of Side Effects of Chemotherapy in Non-Small Cell Lung Cancer Patients (NSCLC) Undergoing Chemotherapy at Dr. M. Djamil General Hospital, Padang, Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |HM Publisher
2022
Benefits of Conventional Chemotherapy in Progressive Disease Patients with Tyrosine-Kinase Inhibitors: A Case Report
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |HM Publisher
2022
Gambaran Riwayat Asma pada Pasien Rinitis Alergi di RSUP Dr. M. Djamil Padang
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 4 |Fakultas Kedokteran, Universitas Andalas
2022
Karakteristik Pasien COVID-19 Simtomatik dan Asimtomatik di Rumah Sakit
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 4 |Fakultas Kedokteran, Universitas Andalas
2022
Profile of Side Effects of Chemotherapy in Non-Small Cell Lung Cancer Patients (NSCLC) Undergoing Chemotherapy at Dr. M. Djamil General Hospital, Padang, Indonesia
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |HM Publisher
2022
Effect of Radon and Lung Cancer Risk: A Narrative Literature Review
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |HM Publisher
2022
Benefits of Conventional Chemotherapy in Progressive Disease Patients with Tyrosine-Kinase Inhibitors: A Case Report
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |HM Publisher
2022
Mediastinal Tumor Thymoma Type B1 T4N2M1B Stage IVB with Multimodality Therapy
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Sinta 3 |Faculty of Mathematics and Natural Sciences (FMIPA), Universitas Negeri Padang, Indonesia
2022
Layanan Hotline Konsultasi Masalah Kesehatan Pasca COVID-19
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |Lembaga Penelitian dan Pengabdian kepada Masyarakat Universitas Riau
2021
Faktor â Faktor yang Mempengaruhi Kejadian Gagal Napas pada Pasien PPOK Eksaserbasi Akut di RSUP Dr. M. Djamil Padang
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |Fakultas Kedokteran, Universitas Andalas
2020
Accuration of Circulating Tumor DNA (ctDNA) in Detection of Epidermal Growth Factor Receptor (EGFR) Mutation in Lung Cancer Patient Type Adenocarcinoma in M Djamil Hospital Padang
Fakultas Kedokteran
Authors: SABRINA ERMAYANTI
Non Kategori |Indonesian Society of Respirology (ISR)
